MVP: Hogan Lovells' Adam Golden
Adam Golden of Hogan Lovells has been involved in several high-profile life science deals over the last year — including the $9 billion acquisition of Juno Therapeutics by Celgene, one of...To view the full article, register now.
Already a subscriber? Click here to view full article